Heuszel

Business

Impact Biomedical CEO Frank D. Heuszel buys $1,128 in common stock By Investing.com

Frank D. Heuszel, the Chief Executive Officer of Impact Biomedical Inc. (NASDAQ:IBO), recently purchased 500 shares of the company's common…

Read More »
Back to top button